Cas:871-37-4 (carboxymethyl)dimethyloleylammonium hydroxide manufacturer & supplier

We serve Chemical Name:(carboxymethyl)dimethyloleylammonium hydroxide CAS:871-37-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(carboxymethyl)dimethyloleylammonium hydroxide

Chemical Name:(carboxymethyl)dimethyloleylammonium hydroxide
CAS.NO:871-37-4
Synonyms:(Carboxymethyl)dimethyloleylammonium hydroxide;UNII-T4052HS20F;Oleyl betaine;EINECS 212-806-1;Oleyl dimethyl glycine;Oleyldimethylbetaine;9-Octadecen-1-aminium,N-(carboxymethyl)-N,N-dimethyl-,hydroxide,inner salt,(Z)
Molecular Formula:C22H43NO2
Molecular Weight:353.58200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:40.13000
Exact Mass:353.32900
LogP:4.85020

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (Carboxymethyl)dimethyloleylammonium hydroxide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9-Octadecen-1-aminium,N-(carboxymethyl)-N,N-dimethyl-,hydroxide,inner salt,(Z) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Oleyl betaine Use and application,Oleyl dimethyl glycine technical grade,usp/ep/jp grade.


Related News: The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. ethyl 6-(((tert-butyldiphenylsilyl)oxy)methyl)benzo[4,5]imidazo[2,1-b]thiazole-2-carboxylate manufacturers The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. Reflexin-pentabenzoat suppliers Contract research organisation Charles River Laboratories International Inc. today announced plans for an €8M expansion of its testing capabilities at its Ballina, Co. Mayo site that will give an additional 1,500m2 of lab space and create up to 90 new skilled roles over the next three years. methyl O2,O3-isopropylidene-4-vinyl-α-L-talo-6-deoxy-hexopyranoside vendor & factory The review by EMA’s safety committee (PRAC) supported by experts from the Committee for Advanced Therapies (CAT) found that the viral vector was unlikely to be the cause. ,The growing use of biocatalysis in pharmaceutical chemistry promises to deliver on this need, while also offering substantial cost savings and faster time to market for urgently needed therapeutics.